Adjustment of therapy in a patient planning a pregnancy aims to use medications that support disease control in the mother and are considered safe for the fetus ...

The current evidence indicates that synthetic DMARDs compatible with pregnancy include azathioprine or mercaptopurine, chloroquine, colchicine, cyclosporine, ...

EULAR recommendations for women's health and the management of ... Recommendation 8: Drugs for the Prevention and Management of SLE flares during pregnancy.

14 окт. 2020 г. · We present the first consensus-based core data set for pregnancy registries in rheumatology. The comprehensive list of 51 main items should be ...

Effective drug treatment of active inflammatory rheumatic disease is possible with reasonable safety for the fetus/child during pregnancy and lactation. The ...

8 февр. 2024 г. · The EULAR regularly publishes evidence-based recommendations on therapies during pregnancy and breastfeeding [4]. Ideally, a patient with SLE ...

EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic ...

Evidence-based international guidelines and recommendations from EULAR 2016 and ACR 2020 help when choosing a pregnancy-compatible treatment option [1, 2].

et al. EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with ... The guideline · Conventional synthetic...

In patients with SLE and no history of thrombosis or pregnancy complications: a. with high-risk aPL profile, prophylactic treatment with LDA is recommended. LoE ...